Stephen E. Jones

University of Arizona College of Medicine 
"Stephen Jones"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Morden JP, Alvarez I, Bertelli G, et al. (2017) Long-Term Follow-Up of the Intergroup Exemestane Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016705640
Blum JL, Flynn PJ, Yothers G, et al. (2017) Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016714147
Finn RS, Martin M, Rugo HS, et al. (2016) Palbociclib and Letrozole in Advanced Breast Cancer. The New England Journal of Medicine. 375: 1925-1936
O'Shaughnessy JA, Koeppen H, Xiao Y, et al. (2015) Patients with Slowly Proliferative Early Breast Cancer have Low 5-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Jones SE, Collea R, Paul D, et al. (2013) Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study. The Lancet. Oncology. 14: 1121-8
Jacquin JP, Jones S, Magné N, et al. (2012) Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials. Breast Cancer Research and Treatment. 134: 903-13
Hezewijk Mv, Hille ETM, Putter H, et al. (2012) 391 Higher Risk of Locoregional Recurrences for Women Treated with Mastectomy Compared to Breast-Conserving Therapy in Postmenopausal Women with Early Breast Cancer Treated on the TEAM Trial European Journal of Cancer. 48
Water Wvd, Bastiaannet E, Seynaeve C, et al. (2012) 22 Increased Breast Cancer Recurrence in Elderly Patients is Explained by a Higher Risk of Distant Recurrence – a TEAM Study Analysis European Journal of Cancer. 48
Fontein D, Hadji P, Seynaeve C, et al. (2012) 87. Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors – A TEAM trial analysis Ejso. 38: 758-759
Loesch D, Robert N, Jones S, et al. (2011) Phase II Trial of a Novel Paclitaxel Schedule As Single-Agent, First-Line Therapy for HER-2/neu-Negative Metastatic Breast Cancer: A Community-Based Study. Journal of Oncology Practice. 2: 268-73
See more...